Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany.

G. Laux; B. Heeg; B.A. van Hout; A. Mehnert

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany.

Translated title of the contribution: Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany.

G. Laux, B. Heeg, B.A. van Hout, A. Mehnert

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany.
Original language	Undefined/Unknown
Pages (from-to)	49-61
Number of pages	13
Journal	PharmacoEconomics
Volume	23 Suppl 1
Publication status	Published - 2005

Cite this

@article{ec390b089c61401092c22dbdd7b6feed,

title = "Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany.",

author = "G. Laux and B. Heeg and \{van Hout\}, B.A. and A. Mehnert",

year = "2005",

language = "Undefined/Unknown",

volume = "23 Suppl 1",

pages = "49--61",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis",

}